HFM information and reviews
HFM
96%
Octa information and reviews
Octa
94%
FXCC information and reviews
FXCC
92%
FxPro information and reviews
FxPro
89%
FBS information and reviews
FBS
88%
Vantage information and reviews
Vantage
85%

The Fed has the market's back


30 April 2020

The Federal Reserve will do "whatever it takes for as long as needed" to protect the US economy. This is the one statement that summarises the latest FOMC monetary policy decision perfectly.

As widely anticipated, the Fed voted unanimously to keep its funds rate unchanged within the range of 0 – 0.25% and it also left the interest rate on excess reserves at 0.1%. Near-zero interest rates will be in place for a long time given that the committee expects to maintain this target range until it’s “confident that the economy has weathered the health crisis and is on track to achieve its maximum employment and price stability goals”.

According to the Fed’s statement, the economy is currently facing hits from several fronts due to the coronavirus. Sharp declines in economic activity, the surge in job losses, weaker demand, low inflation and external shocks from abroad will all weigh heavily on economic activity and pose considerable risks to the outlook over the medium-term.

While the Fed did not specify any limit on the upcoming quantitative easing, it made it clear that they will continue to purchase Treasury securities and mortgage back securities to support “smooth market functioning”. Businesses should not worry about short term funding as the Fed remains committed to offering large scale overnight and term repos.

The risks imposed by the virus on the economy will not be a short term one but more likely over a longer period, suggesting that interest rates will remain near zero for several years to come. The other conclusion we can draw from the Fed’s statement and Powell’s press conference is that the recovery will more likely be a U-shaped one and has little chance of being V-shaped. Of course, the issue here is that the stock market’s performance over the past six weeks certainly looks V-shaped on account of all the fiscal and monetary easing we have seen so far and the commitment of more to come if needed.

However, today’s sharp rally in US stocks which sent the S&P 500 2.7% by the close and 34% higher since the bottom on March 23 is due to early positive results in Gilead’s remdesivir studies as a virus drug. This tell us that biopharmaceutical companies have clearly become the leading indicator for the market. Any positive news towards finding a treatment or a vaccine to Covid-19 is driving risk-on behaviour. The other factor feeding appetite to riskier assets is the gradual lifting of lockdowns that we’ve seen in several US states and European countries.

While these are legitimate reasons to become more risk-seeking, investors should take other factors into consideration as well. Valuations are no longer cheap, economic activity will take a long time to recover, many jobs are unsecured, consumer behaviour has changed, millions of employees have already been laid off and we’re still unsure about the risks of a second wave of coronavirus. In fact, that’s the reason why gold is still near 7-year highs despite the optimism reflected in equities. At this stage I would consider a cautious approach to risk assets.

Today sees the ECB meeting and a central bank which is facing even more challenging times than the Fed, given that the fiscal boost to Eurozone nations is relatively muted compared to the US. While the bank is not expected to take any new action, having already launched its Pandemic Emergency Purchase Program five week ago, investors want to hear that the ECB will follow the “whatever it takes” approach and signal their readiness to act. Markets also expect the ECB President Christine Lagarde to remind Eurozone leaders that further collective action around fiscal policies is required.

#source

Share: Tweet this or Share on Facebook


Related

Yen stabilizes as Japan ramps up intervention warning
Yen stabilizes as Japan ramps up intervention warning

Threats of FX intervention help yen to stabilize near three-decade lows. Dollar and stocks take a step back, Bitcoin jumps in anticipation of halving. Shortage of liquidity could be an important market theme this week.

26 Mar 2024

Stocks at fresh records even as dollar bounces back
Stocks at fresh records even as dollar bounces back

Wall Street leads rally in equity markets, fuelled by rate cut optimism. US dollar stages surprise rebound amid US exceptionalism. Pound slides on BoE's dovish tilt, yen steadies, PBOC loosens grip on yuan.

22 Mar 2024

Dollar rises as Fed enters spotlight, yen plummets
Dollar rises as Fed enters spotlight, yen plummets

US dollar gains as traders brace for hawkish Fed. Yen tumbles despite BoJ's historic decision. Loonie slides on cooler than expected Canadian inflation. Wall Street gains ahead of Fed, oil extends advance.

20 Mar 2024

BoJ hikes, scraps yield curve control, but yen slumps

BoJ ends negative rates and yield curve control in historic move, but yen can't catch a break as Ueda signals ongoing accommodative stance.

19 Mar 2024

Dollar recovers, equities stall after US data releases
Dollar recovers, equities stall after US data releases

Dollar stages comeback as US data fuels speculation of fewer Fed cuts. Stocks and Bitcoin take a step back, oil climbs after Ukraine drone attacks. Yen traders play the guessing game ahead of next week's rate decision.

15 Mar 2024

US PPI and retail sales data enter the limelight
US PPI and retail sales data enter the limelight

After hot CPI inflation, dollar awaits PPI and retail sales data. Yen on the back foot as BoJ March hike bets decrease - S&P 500 and Nasdaq pull back, gold rebounds

14 Mar 2024


Forex Forecasts

MultiBank Group information and reviews
MultiBank Group
84%
XM information and reviews
XM
82%
FP Markets information and reviews
FP Markets
81%
FXTM information and reviews
FXTM
80%
AMarkets information and reviews
AMarkets
79%
BlackBull information and reviews
BlackBull
78%

© 2006-2024 Forex-Ratings.com

The usage of this website constitutes acceptance of the following legal information.
Any contracts of financial instruments offered to conclude bear high risks and may result in the full loss of the deposited funds. Prior to making transactions one should get acquainted with the risks to which they relate. All the information featured on the website (reviews, brokers' news, comments, analysis, quotes, forecasts or other information materials provided by Forex Ratings, as well as information provided by the partners), including graphical information about the forex companies, brokers and dealing desks, is intended solely for informational purposes, is not a means of advertising them, and doesn't imply direct instructions for investing. Forex Ratings shall not be liable for any loss, including unlimited loss of funds, which may arise directly or indirectly from the usage of this information. The editorial staff of the website does not bear any responsibility whatsoever for the content of the comments or reviews made by the site users about the forex companies. The entire responsibility for the contents rests with the commentators. Reprint of the materials is available only with the permission of the editorial staff.
We use cookies to improve your experience and to make your stay with us more comfortable. By using Forex-Ratings.com website you agree to the cookies policy.